NasdaqCM - Delayed Quote USD

TNF Pharmaceuticals, Inc. (TNFA)

0.1680
+0.0084
+(5.26%)
At close: June 6 at 4:00:00 PM EDT
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
21,421.0840
17,862.2700
17,539.9800
24,812.9330
Total Liabilities Net Minority Interest
6,701.3400
5,088.6270
2,844.9240
1,165.7590
Total Equity Gross Minority Interest
14,719.7440
12,773.6430
14,695.0560
23,647.1740
Total Capitalization
14,719.7440
12,773.6430
14,695.0560
23,647.1740
Preferred Stock Equity
5,074.5280
548.5950
144.5240
144.5240
Common Stock Equity
9,645.2160
12,225.0480
14,550.5320
23,502.6500
Capital Lease Obligations
10.5790
48.8700
141.7210
149.1510
Net Tangible Assets
4,221.2050
2,275.1040
4,196.5170
13,148.6350
Working Capital
2,710.6260
828.2530
2,632.7960
11,625.5190
Invested Capital
9,645.2160
12,225.0480
14,550.5320
23,502.6500
Tangible Book Value
-853.3230
1,726.5090
4,051.9930
13,004.1110
Total Debt
10.5790
48.8700
141.7210
149.1510
Share Issued
3,363.6030
2,018.8560
1,315.6660
1,255.7700
Ordinary Shares Number
3,363.6030
2,018.8560
1,315.6660
1,255.7700
Preferred Shares Number
72.9920
--
--
--
12/31/2021 - 1/23/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers